{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:10:11Z","timestamp":1759093811641,"version":"3.44.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ijcard.2022.04.023","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T20:59:33Z","timestamp":1649797173000},"page":"99-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["2021. The year in review. Structural heart interventions"],"prefix":"10.1016","volume":"359","author":[{"given":"Konstantinos","family":"Marmagkiolis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cezar A.","family":"Iliescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy L.","family":"Grines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Matar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Cilingiroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Dec 22 2021","key":"10.1016\/j.ijcard.2022.04.023_bb0005","article-title":"ESC\/EACTS guidelines for the management of valvular heart disease","author":"Vahanian","year":"2021","journal-title":"EuroIntervention."},{"issue":"5","key":"10.1016\/j.ijcard.2022.04.023_bb0010","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ijcard.2022.04.023_bb0015","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2020.12.052","article-title":"Outcomes 2 years after Transcatheter aortic valve replacement in patients at low surgical risk","volume":"77","author":"Leon","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2022.04.023_bb0020","article-title":"Complete 2-year follow-up from the Evolut low risk trial","author":"Forrest","year":"2021","journal-title":"Presented EuroPCR"},{"issue":"16","key":"10.1016\/j.ijcard.2022.04.023_bb0025","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4244\/EIJ-D-21-00613","article-title":"Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry","volume":"17","author":"Witberg","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.04.023_bb0030","series-title":"Presented at: TCT 2021. Orlando, FL","article-title":"5-year clinician and echocardiographic outcomes from the randomized SURTAVI trial","author":"NM VM","year":"2021"},{"issue":"10","key":"10.1016\/j.ijcard.2022.04.023_bb0035","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/CIRCULATIONAHA.120.048048","article-title":"Transcatheter aortic valve replacement in bicuspid aortic valve stenosis","volume":"143","author":"Vincent","year":"2021","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ijcard.2022.04.023_bb0040","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jcin.2020.02.008","article-title":"Transcatheter aortic valve replacement in low-risk patients with symptomatic severe bicuspid aortic valve stenosis","volume":"13","author":"Waksman","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.04.023_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carrev.2021.06.123","article-title":"Transcatheter aortic valve replacement in low-risk bicuspid and tricuspid patients: meta-analysis","volume":"33","author":"Medranda","year":"2021","journal-title":"Cardiovasc. Revasc. Med."},{"key":"10.1016\/j.ijcard.2022.04.023_bb0050","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/CIRCULATIONAHA.121.057639","article-title":"Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: the AVATAR trial","volume":"145","author":"Banovic","year":"2022","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ijcard.2022.04.023_bb0055","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.jcin.2021.06.041","article-title":"ACTIVATION (PercutAneous coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial","volume":"14","author":"Patterson","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.04.023_bb0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.amjcard.2021.02.040","article-title":"Atrial fibrillation and outcomes after Transcatheter or surgical aortic valve replacement (from the PARTNER 3 trial)","volume":"148","author":"Shahim","year":"2021","journal-title":"Am. J. Cardiol."},{"issue":"14","key":"10.1016\/j.ijcard.2022.04.023_bb0065","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jcin.2021.05.026","article-title":"Postoperative atrial fibrillation or flutter following Transcatheter or surgical aortic valve replacement: PARTNER 3 trial","volume":"14","author":"Shahim","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"issue":"14","key":"10.1016\/j.ijcard.2022.04.023_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.020906","article-title":"Predictors of permanent pacemaker implantation in patients undergoing transcatheter aortic valve replacement - A systematic review and meta-analysis","volume":"10","author":"Ullah","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"27","key":"10.1016\/j.ijcard.2022.04.023_bb0075","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/eurheartj\/ehab213","article-title":"A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial","volume":"42","author":"Lansky","year":"2021","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.ijcard.2022.04.023_bb0080","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.jacc.2021.03.007","article-title":"Impact of anesthesia strategy and valve type on clinical outcomes after transcatheter aortic valve replacement","volume":"77","author":"Feistritzer","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15","key":"10.1016\/j.ijcard.2022.04.023_bb0085","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without Clopidogrel after Transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.ijcard.2022.04.023_bb0090","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without Clopidogrel after Transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.ijcard.2022.04.023_bb0095","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","article-title":"Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR","volume":"385","author":"Van Mieghem","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.ijcard.2022.04.023_bb0100","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.jcin.2021.09.019","article-title":"Subclinical leaflet thrombosis after Transcatheter aortic valve replacement: a meta-analysis","volume":"14","author":"Bogyi","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"issue":"24","key":"10.1016\/j.ijcard.2022.04.023_bb0105","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.jacc.2020.04.043","article-title":"Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy","volume":"75","author":"Makkar","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2022.04.023_bb0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1911426","article-title":"Reduced leaflet motion after transcatheter aortic-valve replacement","volume":"382","author":"De Backer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2022.04.023_bb0115","article-title":"Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: the randomized ATLANTIS trial","volume":"2021","author":"Collet","year":"2021","journal-title":"Presented ACC 2021"},{"key":"10.1016\/j.ijcard.2022.04.023_bb0120","article-title":"Percutaneous versus surgical transaxillary access for transcatheter aortic valve replacement: a propensity-matched analysis of the US experience","author":"Chung","year":"2021","journal-title":"EuroIntervention"},{"issue":"4","key":"10.1016\/j.ijcard.2022.04.023_bb0125","first-page":"767","article-title":"A meta-analysis of transcarotid versus transfemoral transcatheter aortic valve replacement","volume":"98","author":"McGrath","year":"2021","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.04.023_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.731639","article-title":"Clinical outcome and safety of transcaval access for transcatheter aortic valve replacement as compared to other alternative approaches","volume":"8","author":"Barbash","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2022.04.023_bb0135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCULATIONAHA.121.057856","article-title":"Comparison of a pure plug-based versus a primary suture-based vascular closure device strategy for transfemoral transcatheter aortic valve replacement: the CHOICE-CLOSURE randomized clinical trial","volume":"145","author":"Abdel-Wahab","year":"2022","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ijcard.2022.04.023_bb0140","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.jcin.2021.07.004","article-title":"5-year outcomes comparing surgical versus transcatheter aortic valve replacement in patients with chronic kidney disease","volume":"14","author":"Garcia","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"issue":"5","key":"10.1016\/j.ijcard.2022.04.023_bb0145","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00392-020-01787-7","article-title":"Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial","volume":"110","author":"Chandrasekhar","year":"2021","journal-title":"Clin. Res. Cardiol."},{"issue":"13","key":"10.1016\/j.ijcard.2022.04.023_bb0150","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jcin.2019.04.052","article-title":"Preventing coronary obstruction during transcatheter aortic valve replacement: from computed tomography to BASILICA","volume":"12","author":"Lederman","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"issue":"9","key":"10.1016\/j.ijcard.2022.04.023_bb0155","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jcin.2021.02.035","article-title":"Preventing coronary obstruction during transcatheter aortic valve replacement: results from the multicenter international BASILICA registry","volume":"14","author":"Khan","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"issue":"5","key":"10.1016\/j.ijcard.2022.04.023_bb0160","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.010238","article-title":"BASILICA trial: one-year outcomes of Transcatheter electrosurgical leaflet laceration to prevent TAVR coronary obstruction","volume":"14","author":"Khan","year":"2021","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"11","key":"10.1016\/j.ijcard.2022.04.023_bb0165","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jcin.2021.02.030","article-title":"Effect of transcatheter aortic valve replacement on concomitant mitral regurgitation and its impact on mortality","volume":"14","author":"Witberg","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.04.023_bb0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2021.03.071","article-title":"Clinical impact and evolution of mitral regurgitation after TAVI using the new generation self-expandable valves","volume":"335","author":"Giannini","year":"2021","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2022.04.023_bb0175","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.010437","article-title":"Incidence and clinical significance of worsening tricuspid regurgitation following surgical or transcatheter aortic valve replacement: analysis from the PARTNER IIA trial","volume":"14","author":"Cremer","year":"2021","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"7","key":"10.1016\/j.ijcard.2022.04.023_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.010336","article-title":"Impact of Predilation during Transcatheter aortic valve replacement: insights from the PARTNER 3 trial","volume":"14","author":"Ternacle","year":"2021","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"1","key":"10.1016\/j.ijcard.2022.04.023_bb0185","first-page":"25","article-title":"TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients","volume":"7","author":"Monlezun","year":"2021","journal-title":"Cardiooncology"},{"key":"10.1016\/j.ijcard.2022.04.023_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.641268","article-title":"TAVR in Cancer patients: comprehensive review, Meta-analysis, and Meta-regression","volume":"8","author":"Marmagkiolis","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"23","key":"10.1016\/j.ijcard.2022.04.023_bb0195","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jacc.2021.07.058","article-title":"Transcatheter mitral valve therapy in the United States: a report from the STS-ACC TVT registry","volume":"78","author":"Mack","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2022.04.023_bb0200","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jacc.2020.12.047","article-title":"3-year outcomes of Transcatheter mitral valve repair in patients with heart failure","volume":"77","author":"Mack","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.ijcard.2022.04.023_bb0205","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jcin.2021.04.001","article-title":"2-year outcomes for Transcatheter repair in patients with mitral regurgitation from the CLASP study","volume":"14","author":"Szerlip","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.04.023_bb0210","article-title":"Transcatheter edge-to-edge repair in COAPT-ineligible patients: incidence and predictors of 2-year good outcome","author":"Scotti","year":"2021","journal-title":"Can. J. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2022.04.023_bb0215","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jacc.2020.07.010","article-title":"Predictors of clinical response to Transcatheter reduction of secondary mitral regurgitation: the COAPT trial","volume":"76","author":"Grayburn","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2022.04.023_bb0220","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jchf.2021.04.011","article-title":"Sex-specific outcomes of Transcatheter mitral-valve repair and medical therapy for mitral regurgitation in heart failure","volume":"9","author":"Kosmidou","year":"2021","journal-title":"JACC Heart Fail."},{"issue":"8","key":"10.1016\/j.ijcard.2022.04.023_bb0225","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jchf.2021.03.011","article-title":"Impact of diabetes on outcomes after Transcatheter mitral valve repair in heart failure: COAPT trial","volume":"9","author":"Shahim","year":"2021","journal-title":"JACC Heart Fail."},{"issue":"4","key":"10.1016\/j.ijcard.2022.04.023_bb0230","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.010300","article-title":"Implications of atrial fibrillation on the mechanisms of mitral regurgitation and response to MitraClip in the COAPT trial","volume":"14","author":"Gertz","year":"2021","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"23","key":"10.1016\/j.ijcard.2022.04.023_bb0235","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.jcin.2020.09.023","article-title":"Impact of COPD on outcomes after MitraClip for secondary mitral regurgitation: the COAPT trial","volume":"13","author":"Saxon","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"issue":"18","key":"10.1016\/j.ijcard.2022.04.023_bb0240","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.jcin.2021.07.029","article-title":"Mitral valve surgery after Transcatheter edge-to-edge repair: mid-term outcomes from the CUTTING-EDGE international registry","volume":"14","author":"Kaneko","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"issue":"7","key":"10.1016\/j.ijcard.2022.04.023_bb0245","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/eurheartj\/ehab496","article-title":"Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction","volume":"43","author":"Haberman","year":"2022","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2022.04.023_bb0250","first-page":"E123","article-title":"Feasibility of same-day discharge approach after transcatheter mitral valve repair procedures","volume":"33","author":"Marmagkiolis","year":"2021","journal-title":"J. Invas. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322005034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322005034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:57:18Z","timestamp":1759093038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527322005034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":50,"alternative-id":["S0167527322005034"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.04.023","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2021. The year in review. Structural heart interventions","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}